Immunizations with unmodified tumor cells and simultaneous COX-2 inhibition eradicate malignant rat brain tumors and induce a long-lasting CD8+ T cell memory

被引:9
作者
Eberstal, Sofia [1 ,2 ]
Fritzell, Sara [1 ]
Sanden, Emma [1 ]
Visse, Edward [1 ]
Darabi, Anna [1 ]
Siesjo, Peter [1 ]
机构
[1] Lund Univ, Dept Clin Sci, Div Neurosurg, Glioma Immunotherapy Grp, SE-22184 Lund, Sweden
[2] Lund Univ, Lund Stem Cell Ctr, SE-22184 Lund, Sweden
关键词
Malignant brain tumors; Immunotherapy; COX-2; inhibition; Immunological memory; CD8(+)T cells; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; IFN-GAMMA; PROGNOSTIC-SIGNIFICANCE; ANTITUMOR IMMUNITY; CD8-T-CELL MEMORY; CD4-T-CELL HELP; GM-CSF; GLIOMA; IMMUNOTHERAPY; EFFECTOR;
D O I
10.1016/j.jneuroim.2014.06.019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Malignant brain tumors induce pronounced immunosuppression, which diminishes immune responses generated by immunotherapy. Here we report that peripheral immunotherapy, using irradiated unmodified whole tumor cells, and systemic cyclooxygenase-2 inhibition induce cure in glioma-bearing rats (60% cure rate), whereas neither monotherapy was sufficient to cure any animal. Moreover, the combined therapy protected against secondary tumor challenges (89% cure rate) and the secondary immune response was correlated with increased plasma interferon-gamma levels and CD8(+)T cells.systemically and intratumorally. In conclusion, we demonstrate that cyclooxygenase-2 inhibition is sufficient to render unmodified tumor cells immunogenic in immunotherapy of experimental brain tumors. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:161 / 167
页数:7
相关论文
共 35 条
[1]   Celecoxib for the prevention of colorectal adenomatous polyps [J].
Arber, Nadir ;
Eagle, Craig J. ;
Spicak, Julius ;
Racz, Istvan ;
Dite, Petr ;
Hajer, Jan ;
Zavoral, Miroslav ;
Lechuga, Maria J. ;
Gerletti, Paola ;
Tang, Jie ;
Rosenstein, Rebecca B. ;
Macdonald, Katie ;
Bhadra, Pritha ;
Fowler, Robert ;
Wittes, Janet ;
Zauber, Ann G. ;
Solomon, Scott D. ;
Levin, Bernard .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) :885-895
[2]   Aspirin and cancer risk: an updated quantitative review to 2005 [J].
Bosetti, Cristina ;
Gallus, Silvano ;
La Vecchia, Carlo .
CANCER CAUSES & CONTROL, 2006, 17 (07) :871-888
[3]   Human CD4+ effector memory T cells persisting in the microenvironment of lung cancer xenografts are activated by local delivery of IL-12 to proliferate, produce IFN-γ, and eradicate tumor cells [J].
Broderick, L ;
Yokota, SJ ;
Reineke, J ;
Mathiowitz, E ;
Stewart, CC ;
Barcos, M ;
Kelleher, RJ ;
Bankert, RB .
JOURNAL OF IMMUNOLOGY, 2005, 174 (02) :898-906
[4]  
Buccoliero AM, 2006, CLIN NEUROPATHOL, V25, P59
[5]   Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement [J].
Cuzick, Jack ;
Otto, Florian ;
Baron, John A. ;
Brown, Powel H. ;
Burn, John ;
Greenwald, Peter ;
Jankowski, Janusz ;
La Vecchia, Carlo ;
Meyskens, Frank ;
Senn, Hans Joerg ;
Thun, Michael .
LANCET ONCOLOGY, 2009, 10 (05) :501-507
[6]  
DeLong P, 2003, CANCER RES, V63, P7845
[7]   Celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma [J].
Dovedi, Simon J. ;
Kirby, John A. ;
Davies, Barry R. ;
Leung, Hing ;
Kelly, John D. .
EUROPEAN UROLOGY, 2008, 54 (03) :621-630
[8]   Intratumoral COX-2 inhibition enhances GM- CSF immunotherapy against established mouse GL261 brain tumors [J].
Eberstal, Sofia ;
Sanden, Emma ;
Fritzell, Sara ;
Darabi, Anna ;
Visse, Edward ;
Siesjo, Peter .
INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (11) :2748-2753
[9]   Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors [J].
Eberstal, Sofia ;
Badn, Wiaam ;
Fritzell, Sara ;
Esbjornsson, Magnus ;
Darabi, Anna ;
Visse, Edward ;
Siesjo, Peter .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (08) :1191-1199
[10]   IFNγ in combination with IL-7 enhances immunotherapy in two rat glioma models [J].
Fritzell, Sara ;
Eberstal, Sofia ;
Sanden, Emma ;
Visse, Edward ;
Darabi, Anna ;
Siesjo, Peter .
JOURNAL OF NEUROIMMUNOLOGY, 2013, 258 (1-2) :91-95